About this trial
The primary purpose of this study is to attempt to replicate and extend promising pilot findings regarding the cognitive benefits of in-home neuro-exergaming with iPACES (interactive Physical and Cognitive Exercise System v3) for persons with mild cognitive impairment (MCI), to evaluate effects for persons with Parkinson's Disease (PD). Participants will include persons with PD, and potentially, also their co-residing partner, who will exercise at home or accessible location, 3-5 times per week for at least 6 months, with follow-up one month after the main intervention. All participation is "remote" (completed at home, or location of choice), utilizing either one's own equipment ("bring-your-own-devices" BYODs: pedaler, phone/tablet, smart-watch) or some equipment which may be supplied by the grant-funded study and shipped directly to the home; all study measures are completed remotely (e.g., via phone app, website, biometric device, videoconference, email, snail mail, etc.).
Eligibility criteria
Qualifiers
50 years of age or older
meets criteria for MCI (per site staff/MD/neuropsychologist and confirmed by study-administered Montreal Cognitive Assessment; MoCA; score = between 16-26, non-inclusive; Milani, 2018)
Disqualifiers
already exercising at recommended levels (45 min of moderate intensity aerobic exercise 5-7x/wk)
significant history of cardiovascular problems
significant history of stroke
significant history of memory problems (e.g., dementia/Alzheimer's)
Trial design
Treatments tested in this trial
- iPACES (interactive Physical and Cognitive Exercise System)
- PACE (Physical and Cognitive Exercise)
Treatment groups
Sponsors and collaborators
iPACES LLC
Lead sponsor
Pacific Brain Health Center
Collaborator
1st Playable Productions
Collaborator
Adirondack Neuropsychological Associates
Collaborator
Albany Medical College
Collaborator
Center for Balance, Mobility & Wellness at Gordon College
Collaborator